Form 4 for CI Cigna
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001225208-23-002993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-28 | 2023-02-24 | CI | Cordani David | COB, CEO, Dir | A - Grant | $0.00 | +37.5K | 160.4K | +31% | $0 | |
| 2023-02-28 | 2023-02-27 | CI | Cordani David | COB, CEO, Dir | S - Sale | $294.06 | -20.1K | 120.5K | -14% | -$5.92M | |
| M | 2023-02-28 | 2023-02-24 | CI | Cordani David | COB, CEO, Dir | F - Tax | $294.27 | -19.7K | 158.0K | -11% | -$5.80M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2023-02-24 | A | A | 37,549 | $0.00 | 160,351 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| 2 | Common | Common Stock, $.01 Par Value | 2023-02-27 | S | D | 20,148 | $294.06 | 120,496 | D | — | — | |
| 3 | Common | Common Stock, $.01 Par Value | 2023-02-24 | F | D | 17,401 | $294.27 | 140,644 | D | — | — | (F3) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 4 | Common | Common Stock, $.01 Par Value | 2023-02-24 | F | D | 2,306 | $294.27 | 158,045 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |